Literature DB >> 8564952

A matrix attachment region (MAR)-binding activity due to a p114 kilodalton protein is found only in human breast carcinomas and not in normal and benign breast disease tissues.

J Yanagisawa1, J Ando, J Nakayama, Y Kohwi, T Kohwi-Shigematsu.   

Abstract

A M(r) 114,000 protein (p114) that specifically binds to nuclear matrix attachment DNA (matrix attachment region, MAR) from a breast carcinoma cell line SK-BR-3 was purified to near homogeneity. p114 strongly binds to a wild-type A+T-rich MAR probe with high unwinding propensity with a dissociation constant (Kd) of 10(-9), while it exhibits substantially reduced binding to a mutated A+T-rich non-MAR probe, which lacks unwinding propensity. This binding specificity and affinity is similar to the previously cloned thymocyte-associated MAR-binding protein SATB1. By Southwestern blot analysis, the MAR-binding activity of p114 is detectable in human breast carcinomas but is undetectable in normal breast tissues, benign breast diseases, and immortalized epithelial MCF-10A cells. Thus, the MAR-binding activity of p114 is not merely reflecting cell proliferation, but it strongly associates with breast carcinomas. The p114 MAR-binding activity was found in all 43 human breast carcinoma specimens tested, without exception. Much stronger p114 MAR-binding activity was detected in poorly differentiated than well-differentiated carcinomas. p114 may be a reliable diagnostic and possibly prognostic marker for breast cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8564952

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  S/MARt DB: a database on scaffold/matrix attached regions.

Authors:  Ines Liebich; Jürgen Bode; Matthias Frisch; Edgar Wingender
Journal:  Nucleic Acids Res       Date:  2002-01-01       Impact factor: 16.971

2.  Scaffold/matrix attachment region elements interact with a p300-scaffold attachment factor A complex and are bound by acetylated nucleosomes.

Authors:  Joost H A Martens; Matty Verlaan; Eric Kalkhoven; Josephine C Dorsman; Alt Zantema
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

Review 3.  A mini review of MAR-binding proteins.

Authors:  Tian-Yun Wang; Zhong-Min Han; Yu-Rong Chai; Jun-He Zhang
Journal:  Mol Biol Rep       Date:  2010-02-22       Impact factor: 2.316

Review 4.  Nuclear matrix, dynamic histone acetylation and transcriptionally active chromatin.

Authors:  J R Davie
Journal:  Mol Biol Rep       Date:  1997-08       Impact factor: 2.316

5.  The novel SAR-binding domain of scaffold attachment factor A (SAF-A) is a target in apoptotic nuclear breakdown.

Authors:  F Göhring; B L Schwab; P Nicotera; M Leist; F O Fackelmayer
Journal:  EMBO J       Date:  1997-12-15       Impact factor: 11.598

6.  SAF-Box, a conserved protein domain that specifically recognizes scaffold attachment region DNA.

Authors:  M Kipp; F Göhring; T Ostendorp; C M van Drunen; R van Driel; M Przybylski; F O Fackelmayer
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

7.  DNA-PK-dependent binding of DNA ends to plasmids containing nuclear matrix attachment region DNA sequences: evidence for assembly of a repair complex.

Authors:  Stanley K Mauldin; Robert C Getts; Wenjing Liu; Thomas D Stamato
Journal:  Nucleic Acids Res       Date:  2002-09-15       Impact factor: 16.971

8.  The genomic sequences bound to special AT-rich sequence-binding protein 1 (SATB1) in vivo in Jurkat T cells are tightly associated with the nuclear matrix at the bases of the chromatin loops.

Authors:  I de Belle; S Cai; T Kohwi-Shigematsu
Journal:  J Cell Biol       Date:  1998-04-20       Impact factor: 10.539

9.  Matrix attachment regions as targets for retroviral integration.

Authors:  Chassidy N Johnson; Laura S Levy
Journal:  Virol J       Date:  2005-08-19       Impact factor: 4.099

10.  Upregulation of SATB1 is associated with prostate cancer aggressiveness and disease progression.

Authors:  Sanjeev Shukla; Haripaul Sharma; Ata Abbas; Gregory T MacLennan; Pingfu Fu; David Danielpour; Sanjay Gupta
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.